Drug profile · INN
cariprazine hydrochloride
CARIPRAZINE HYDROCHLORIDE
cariprazine hydrochloride (CARIPRAZINE HYDROCHLORIDE) is a dopamine d2 receptor modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — cariprazine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
cariprazine hydrochloride (CARIPRAZINE HYDROCHLORIDE) is a dopamine d2 receptor modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor modulator
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
AbbVie Cerevel acquisition closes in $8.7B neuroscience deal
AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics, paying $45.00 per share in cash. The deal adds neuroscience assets as investors watch emraclidine, pipeline execution, and future filing catalysts.
AbbVie closes $8.7B Cerevel deal as neuroscience pipeline expands
AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics on August 1, 2024, after U.S. Federal Trade Commission review. The deal adds Cerevel assets to AbbVie’s neuroscience pipeline and sets up follow-on readouts to watch.
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cariprazine hydrochloride?
cariprazine hydrochloride (CARIPRAZINE HYDROCHLORIDE) is a dopamine d2 receptor modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cariprazine hydrochloride?
CARIPRAZINE HYDROCHLORIDE is a marketed brand name for cariprazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cariprazine hydrochloride?
cariprazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.